Related Experiment Video
Updated: Jul 12, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Fertility preservation in gynecologic cancers
1Department of Obstetrics and Gynecology, Joan and Sanford I. Weill Medical College of Cornell University, New York, NY 10021, USA. koktay@fertilitypreservation.org
Current Opinion in Oncology
|September 1, 2007
Summary
Young women undergoing gynecologic cancer treatment have multiple fertility preservation options. Established methods like embryo and oocyte cryopreservation offer high success rates, with newer techniques still under investigation.
Area of Science:
- Reproductive Medicine
- Oncology
- Gynecology
Background:
- Young women treated for gynecologic cancer face risks of premature ovarian failure and infertility.
- Fertility preservation is a critical concern for these patients.
Purpose of the Study:
- To review current fertility preservation options for young women at risk of infertility due to gynecologic cancer treatment.
- To inform clinical practice and patient counseling.
Main Methods:
- Literature review of established and experimental fertility preservation techniques.
- Analysis of success rates and applicability of different methods.
Main Results:
- Embryo cryopreservation is the most established method with success rates approaching fresh embryo transfers.
- Oocyte cryopreservation success rates are improving and nearing those of embryo freezing.
- Aromatase inhibitors can minimize estrogen exposure during stimulation for estrogen-sensitive cancers.
- Ovarian-tissue cryopreservation, in-vitro maturation, and xenografting are less established or experimental.
Conclusions:
- Multiple fertility preservation techniques are available, with others in development.
- All young individuals with gynecologic cancer should receive counseling on fertility preservation options, aligning with ASCO guidelines.
Related Concept Videos
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
